E-LIB Suche - Ergebnisse für: Knudsen, Erik S. - Sprache EN

Search for persons X

Sorted by: Relevance

Sorted by: Year

1

Real-World Experience among Elderly Metastatic Breast Cance..:

O'Connor, Thomas N. ; Schultz, Emily ; Wang, Jianxin...
Cancers. 16 (2024) 9 - p. 1749 , 2024

Link: https://doi.org/10.3390/..

2

The Extracellular Niche and Tumor Microenvironment Enhance ..:

Kumarasamy, Vishnu ; Wang, Jianxin ; Frangou, Costakis...
Cancer Research. 84 (2024) 7 - p. 1115-1132 , 2024

Link: https://doi.org/10.1158/..

3

Cancer takes many paths through G1/S:

Knudsen, Erik S. ; Witkiewicz, Agnieszka K. ; Rubin, Seth M.
Trends in Cell Biology. , 2023

Link: https://doi.org/10.1016/..

4

PROTAC-mediated CDK degradation differentially impacts canc..:

Kumarasamy, Vishnu ; Gao, Zhe ; Zhao, Bosheng...
British Journal of Cancer. 129 (2023) 8 - p. 1238-1250 , 2023

Link: https://doi.org/10.1038/..

5

The BET inhibitor/degrader ARV-825 prolongs the growth arre..:

Finnegan, Ryan M. ; Elshazly, Ahmed M. ; Patel, Nipa H....
Frontiers in Oncology. 12 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

Determinants of response to CDK4/6 inhibitors in the real-w..:

Witkiewicz, Agnieszka K. ; Schultz, Emily ; Wang, Jianxin...
npj Precision Oncology. 7 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

7

CDK/cyclin dependencies define extreme cancer cell-cycle he..:

Knudsen, Erik S. ; Kumarasamy, Vishnu ; Nambiar, Ram...
Cell Reports. 38 (2022) 9 - p. 110448 , 2022

Link: https://doi.org/10.1016/..

8

Real-World Experience with CDK4/6 Inhibitors for Metastatic..:

Knudsen, Erik S ; Schultz, Emily ; Hamilton, Deanna...
The Oncologist. 27 (2022) 8 - p. 646-654 , 2022

Link: https://doi.org/10.1093/..

9

RB loss determines selective resistance and novel vulnerabi..:

Kumarasamy, Vishnu ; Nambiar, Ram ; Wang, Jianxin...
Oncogene. , 2022

Link: https://doi.org/10.1038/..

10

TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of..:

Hamad, Samera H. ; Montgomery, Stephanie A. ; Simon, Jeremy M....
Oncogene. 41 (2022) 25 - p. 3423-3432 , 2022

Link: https://doi.org/10.1038/..

11

Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the ..:

Hamad, Samera H. ; Montgomery, Stephanie A. ; Simon, Jeremy M....
Oncogene. 41 (2022) 39 - p. 4485-4485 , 2022

Link: https://doi.org/10.1038/..

12

Metabolic Reprogramming of Pancreatic Cancer Mediated by CD..:

Franco, Jorge ; Balaji, Uthra ; Freinkman, Elizaveta..
Cell Reports. 32 (2020) 1 - p. 107793 , 2020

Link: https://doi.org/10.1016/..

13

A Phase I Study of Ribociclib Plus Everolimus in Patients w..:

Weinberg, Benjamin A. ; Wang, Hongkun ; Witkiewicz, Agnieszka K....
Journal of Pancreatic Cancer. 6 (2020) 1 - p. 45-54 , 2020

Link: https://doi.org/10.1089/..

14

Pan-cancer molecular analysis of the RB tumor suppressor pa..:

Knudsen, Erik S. ; Nambiar, Ram ; Rosario, Spencer R....
Communications Biology. 3 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

15

p27 allosterically activates cyclin-dependent kinase 4 and ..:

Guiley, Keelan Z. ; Stevenson, Jack W. ; Lou, Kevin...
Science. 366 (2019) 6471 - p. , 2019

Link: https://doi.org/10.1126/..

1-15